“We delivered a third quarter above the high end of our revenue and Adjusted EBITDA guidance, and we are reaffirming our full-year outlook,” said
Financial Highlights for the Three Months Ended
Key Financial Metrics
| Three Months Ended | Year over Year Change | |||||||||
| 2026(2) | 2025 | |||||||||
| GAAP Financial Measures: | (in thousands, except percentages, unaudited) | |||||||||
| Total revenue | $ | 56,283 | $ | 76,323 | (26 | )% | ||||
| Gross profit | $ | 17,345 | $ | 29,979 | (42 | )% | ||||
| Gross margin | 31 | % | 39 | % | ||||||
| Net income (loss) | $ | 40,496 | $ | (22,229 | ) | 282 | % | |||
| Non-GAAP Financial Measures:(1) | ||||||||||
| Adjusted Gross Profit | $ | 24,913 | $ | 40,133 | (38 | )% | ||||
| Adjusted Gross Margin | 44 | % | 53 | % | ||||||
| Adjusted EBITDA | $ | 779 | $ | 12,000 | (94 | )% | ||||
________________________
| (1) | These measures are not calculated in accordance with generally accepted accounting principles in |
| (2) | The net income generated during the three months ended |
Financial Outlook
Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.
For the full year of 2026, we expect:
- Total revenue of
$246 million to$249 million , and - Adjusted EBITDA of
$18 million to$18.5 million .
We have not provided forward-looking guidance for net income (loss), the most directly comparable GAAP measure to Adjusted EBITDA, and therefore have not reconciled guidance for Adjusted EBITDA to net income (loss), because there are items that may impact net income (loss), including stock-based compensation, that are not within our control or cannot be reasonably forecasted.
Quarterly Conference Call Details
We will host a conference call to review the results today,
About Health Catalyst
Available Information
Our investors and others should note that we announce material information to the public about our company, products and services, and other matters related to our company through a variety of means, including our website (https://www.healthcatalyst.com/), our investor relations website (https://ir.healthcatalyst.com/), press releases,
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth, our growth and transformation strategies, our strategic priorities, and our financial outlook for the fourth quarter and full year 2026. Forward-looking statements are subject to risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance.
Important risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) changes in laws and regulations applicable to our business model; (ii) changes in market or industry conditions, regulatory environment, and receptivity to our technology and services; (iii) results of litigation or a security incident; (iv) the loss of one or more key clients or partners, clients reducing or eliminating their spend with us, client churn or down-selling in connection with the migration to Ignite or otherwise; (v) fluctuations in our project-based, non-recurring revenue, (vi) macroeconomic challenges (including high inflationary and/or high interest rate environments, tariffs, or market volatility and measures taken in response thereto), natural disasters or any new public health crises, and regional or global conflicts (including in the
| Condensed Consolidated Balance Sheets | |||||||
| (in thousands, except share and per share data, unaudited) | |||||||
| As of | As of | ||||||
| 2026 | 2025 | ||||||
| (unaudited) | |||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 53,746 | $ | 50,814 | |||
| Short-term investments | 25,245 | 44,918 | |||||
| Accounts receivable, net(1) | 41,333 | 59,128 | |||||
| Prepaid expenses and other assets | 12,643 | 14,447 | |||||
| Total current assets | 132,967 | 169,307 | |||||
| Property and equipment, net | 34,456 | 33,838 | |||||
| Intangible assets, net | 50,077 | 77,678 | |||||
| Operating lease right-of-use assets | 5,604 | 6,640 | |||||
| Goodwill | 11,102 | 209,073 | |||||
| Other assets | 3,213 | 6,107 | |||||
| Total assets | $ | 237,419 | $ | 502,643 | |||
| Liabilities and stockholders’ equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 6,531 | $ | 9,363 | |||
| Accrued liabilities | 25,847 | 18,697 | |||||
| Deferred revenue(1) | 42,109 | 56,107 | |||||
| Operating lease liabilities | 3,660 | 3,779 | |||||
| Current portion of long-term debt | — | 1,627 | |||||
| Total current liabilities | 78,147 | 89,573 | |||||
| Long-term debt, net of current portion | — | 151,624 | |||||
| Deferred revenue, net of current portion | 1,026 | 410 | |||||
| Operating lease liabilities, net of current portion | 12,093 | 14,208 | |||||
| Contingent consideration liabilities | — | 250 | |||||
| Other liabilities | 567 | 798 | |||||
| Total liabilities | 91,833 | 256,863 | |||||
| Stockholders’ equity: | |||||||
| Preferred stock, | — | — | |||||
| Common stock, | 1,620,284 | 1,608,840 | |||||
| Accumulated deficit | (1,475,713 | ) | (1,364,646 | ) | |||
| Accumulated other comprehensive income | 1,015 | 1,586 | |||||
| Total stockholders’ equity | 145,586 | 245,780 | |||||
| Total liabilities and stockholders’ equity | $ | 237,419 | $ | 502,643 | |||
__________________
| (1) | Includes amounts attributable to related party transactions. See Note 18 in our condensed consolidated financial statements. |
| Condensed Consolidated Statements of Operations | |||||||||||||||
| (in thousands, except per share data, unaudited) | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue: | |||||||||||||||
| Technology | $ | 40,686 | $ | 52,051 | $ | 138,949 | $ | 156,409 | |||||||
| Professional services | 15,597 | 24,272 | 58,577 | 80,048 | |||||||||||
| Total revenue | 56,283 | 76,323 | 197,526 | 236,457 | |||||||||||
| Cost of revenue, excluding depreciation and amortization: | |||||||||||||||
| Technology(1)(2)(3) | 16,166 | 17,203 | 51,637 | 53,120 | |||||||||||
| Professional services(1)(2)(3) | 16,076 | 21,304 | 51,525 | 71,045 | |||||||||||
| Total cost of revenue, excluding depreciation and amortization | 32,242 | 38,507 | 103,162 | 124,165 | |||||||||||
| Operating expenses: | |||||||||||||||
| Sales and marketing(1)(2)(3) | 8,563 | 14,361 | 29,508 | 42,305 | |||||||||||
| Research and development(1)(2)(3) | 9,503 | 12,281 | 30,308 | 39,859 | |||||||||||
| General and administrative(1)(2)(3)(4) | 11,999 | 16,069 | 37,887 | 38,515 | |||||||||||
| Depreciation and amortization | 9,728 | 12,614 | 32,822 | 37,618 | |||||||||||
| — | — | 122,548 | 28,769 | ||||||||||||
| Total operating expenses | 39,793 | 55,325 | 253,073 | 187,066 | |||||||||||
| Gain on sale of business | 65,889 | — | 65,889 | — | |||||||||||
| Income (loss) from operations | 50,137 | (17,509 | ) | (92,820 | ) | (74,774 | ) | ||||||||
| Loss on extinguishment of debt | (9,494 | ) | — | (9,494 | ) | — | |||||||||
| Interest and other expense, net | (540 | ) | (4,679 | ) | (8,417 | ) | (11,838 | ) | |||||||
| Income (loss) before income taxes | 40,103 | (22,188 | ) | (110,731 | ) | (86,612 | ) | ||||||||
| Income tax benefit (provision) | 393 | (41 | ) | (336 | ) | (337 | ) | ||||||||
| Net income (loss) attributable to common stockholders | $ | 40,496 | $ | (22,229 | ) | $ | (111,067 | ) | $ | (86,949 | ) | ||||
| Net income (loss) per share, basic | $ | 0.54 | $ | (0.32 | ) | $ | (1.50 | ) | $ | (1.25 | ) | ||||
| Net income (loss) per share, diluted | $ | 0.53 | $ | (0.32 | ) | $ | (1.50 | ) | $ | (1.25 | ) | ||||
| Weighted-average shares outstanding used in calculating net income (loss) per share, basic | 75,386 | 70,377 | 73,990 | 69,525 | |||||||||||
| Weighted-average shares outstanding used in calculating net income (loss) per share, diluted | 75,932 | 70,377 | 73,990 | 69,525 | |||||||||||
_______________
| (1) | Includes stock-based compensation expense as follows: |
| Three Months Ended | Nine Months Ended | ||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||
| Stock-Based Compensation Expense: | (in thousands) | (in thousands) | |||||||||
| Cost of revenue, excluding depreciation and amortization: | |||||||||||
| Technology | $ | 145 | $ | 205 | $ | 335 | $ | 719 | |||
| Professional services | 594 | 991 | 1,488 | 3,187 | |||||||
| Sales and marketing | 1,033 | 2,085 | 2,442 | 6,789 | |||||||
| Research and development | 817 | 972 | 1,773 | 3,421 | |||||||
| General and administrative | 1,488 | 2,786 | 4,518 | 8,789 | |||||||
| Total | $ | 4,077 | $ | 7,039 | $ | 10,556 | $ | 22,905 | |||
_______________
| (2) | Includes acquisition-related costs, net, as follows: |
| Three Months Ended | Nine Months Ended | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| Acquisition-related costs, net: | (in thousands) | (in thousands) | |||||||||||
| Cost of revenue, excluding depreciation and amortization: | |||||||||||||
| Technology | $ | — | $ | 11 | $ | 1 | $ | 118 | |||||
| Professional services | — | 24 | 6 | 200 | |||||||||
| Sales and marketing | 210 | (25 | ) | 213 | 416 | ||||||||
| Research and development | 25 | — | 31 | 357 | |||||||||
| General and administrative | 1,137 | (1,826 | ) | 5,516 | (3,598 | ) | |||||||
| Total | $ | 1,372 | $ | (1,816 | ) | $ | 5,767 | $ | (2,507 | ) | |||
_______________
| (3) | Includes restructuring and other related costs as follows: |
| Three Months Ended | Nine Months Ended | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| Restructuring and other related costs: | (in thousands) | (in thousands) | ||||||||||
| Cost of revenue, excluding depreciation and amortization: | ||||||||||||
| Technology | $ | (18 | ) | $ | 436 | $ | 278 | $ | 837 | |||
| Professional services | 151 | 650 | 717 | 1,792 | ||||||||
| Sales and marketing | 207 | 1,947 | 1,567 | 2,299 | ||||||||
| Research and development | 79 | 1,374 | 1,669 | 3,282 | ||||||||
| General and administrative | 935 | 365 | 2,620 | 501 | ||||||||
| Total | $ | 1,354 | $ | 4,772 | $ | 6,851 | $ | 8,711 | ||||
_______________
| (4) | Includes non-recurring lease-related charges as follows: |
| Three Months Ended | Nine Months Ended | ||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||
| Non-recurring lease-related charges: | (in thousands) | (in thousands) | |||||||||
| General and administrative | $ | — | $ | 6,900 | $ | — | $ | 6,900 | |||
| Total | $ | — | $ | 6,900 | $ | — | $ | 6,900 | |||
| Condensed Consolidated Statements of Cash Flows | |||||||
| (in thousands, unaudited) | |||||||
| Nine Months Ended | |||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities | |||||||
| Net loss | $ | (111,067 | ) | $ | (86,949 | ) | |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||
| Stock-based compensation expense | 10,556 | 22,905 | |||||
| Depreciation and amortization | 32,822 | 37,618 | |||||
| Impairment of long-lived assets | — | 6,900 | |||||
| Non-cash operating lease expense | 1,726 | 2,231 | |||||
| Amortization of debt discount, issuance costs, and deferred financing costs | 1,332 | 2,906 | |||||
| Investment discount and premium accretion | (697 | ) | (1,278 | ) | |||
| Provision for expected credit losses | 1,048 | 1,410 | |||||
| Deferred tax provision | (230 | ) | (114 | ) | |||
| Change in fair value of contingent consideration liabilities | (250 | ) | (7,063 | ) | |||
| Loss on extinguishment of debt | 9,494 | — | |||||
| Gain on sale of business | (65,889 | ) | — | ||||
| 122,548 | 28,769 | ||||||
| Other | 110 | (410 | ) | ||||
| Change in operating assets and liabilities: | |||||||
| Accounts receivable, net | 10,391 | (2,709 | ) | ||||
| Prepaid expenses and other assets | 4,850 | 1,934 | |||||
| Accounts payable, accrued liabilities, and other liabilities | 4,970 | (15,729 | ) | ||||
| Deferred revenue | (1,973 | ) | 3,304 | ||||
| Operating lease liabilities | (2,830 | ) | (2,906 | ) | |||
| Net cash provided by (used in) operating activities | 16,911 | (9,181 | ) | ||||
| Cash flows from investing activities | |||||||
| Proceeds from the sale and maturity of short-term investments | 63,901 | 149,448 | |||||
| Purchase of short-term investments | (43,668 | ) | (57,224 | ) | |||
| Acquisition of businesses, net of cash acquired | — | (41,114 | ) | ||||
| Capitalization of internal-use software | (13,584 | ) | (14,638 | ) | |||
| Purchases of property and equipment | (839 | ) | (695 | ) | |||
| Purchase of intangible assets | (909 | ) | (624 | ) | |||
| Proceeds from the sale of property and equipment | 26 | 31 | |||||
| Proceeds from sale of business | 144,455 | — | |||||
| Net cash provided by investing activities | 149,382 | 35,184 | |||||
| Cash flows from financing activities | |||||||
| Proceeds from employee stock purchase plan | 629 | 1,537 | |||||
| Repurchase of common stock | — | (5,000 | ) | ||||
| Repayment of debt | (163,960 | ) | (231,885 | ) | |||
| Net cash used in financing activities | (163,331 | ) | (235,348 | ) | |||
| Effect of exchange rate changes on cash and cash equivalents | (30 | ) | 5 | ||||
| Net increase (decrease) in cash and cash equivalents | 2,932 | (209,340 | ) | ||||
| Cash and cash equivalents at beginning of period | 50,814 | 249,645 | |||||
| Cash and cash equivalents at end of period | $ | 53,746 | $ | 40,305 | |||
Non-GAAP Financial Measures
To supplement our financial information presented in accordance with GAAP, we believe certain non-GAAP financial measures, including Adjusted Gross Profit, Adjusted Gross Margin, Adjusted EBITDA, Adjusted Cost of Revenue, Adjusted Operating Expenses, Adjusted Net Income, and Adjusted Net Income per share, basic and diluted are useful in evaluating our operating performance. For example, we exclude stock-based compensation expense because it is non-cash in nature and excluding this expense provides meaningful supplemental information regarding our operational performance and allows investors the ability to make more meaningful comparisons between our operating results and those of other companies. We use this non-GAAP financial information to evaluate our ongoing operations, as a component in determining employee bonus compensation, and for internal planning and forecasting purposes.
We believe that non-GAAP financial information, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. A reconciliation is provided below for each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.
Adjusted Gross Profit and Adjusted Gross Margin
Gross profit is a GAAP financial measure that is calculated as revenue less cost of revenue, including depreciation and amortization of capitalized software development costs and acquired technology. We calculate gross margin as gross profit divided by our revenue. Adjusted Gross Profit is a non-GAAP financial measure that we define as gross profit, adjusted for (i) depreciation and amortization, (ii) stock-based compensation, (iii) acquisition-related costs, net, and (iv) restructuring and other related costs, as applicable. We define Adjusted Gross Margin as our Adjusted Gross Profit divided by our revenue. We believe Adjusted Gross Profit and Adjusted Gross Margin are useful to investors as they eliminate the impact of certain non-cash expenses and allow a direct comparison of these measures between periods without the impact of non-cash expenses and certain other non-recurring operating expenses.
We present both of these measures for our technology and professional services business. We believe these non-GAAP financial measures are useful in evaluating our operating performance compared to that of other companies in our industry, as these metrics generally eliminate the effects of certain items that may vary from company to company for reasons unrelated to overall profitability.
The following is a reconciliation of our Adjusted Gross Profit and Adjusted Gross Margin, in total and for technology and professional services, to gross profit and gross margin, the most directly comparable financial measures calculated in accordance with GAAP for the three months ended
| Three Months Ended | |||||||||||
| (in thousands, except percentages) | |||||||||||
| Technology | Professional Services | Total | |||||||||
| Revenue | $ | 40,686 | $ | 15,597 | $ | 56,283 | |||||
| Cost of revenue, excluding depreciation and amortization | (16,166 | ) | (16,076 | ) | (32,242 | ) | |||||
| Amortization of intangible assets, cost of revenue | (3,614 | ) | — | (3,614 | ) | ||||||
| Depreciation of property and equipment, cost of revenue | (3,082 | ) | — | (3,082 | ) | ||||||
| Gross profit | 17,824 | (479 | ) | 17,345 | |||||||
| Gross margin | 44 | % | (3) % | 31 | % | ||||||
| Add: | |||||||||||
| Amortization of intangible assets, cost of revenue | 3,614 | — | 3,614 | ||||||||
| Depreciation of property and equipment, cost of revenue | 3,082 | — | 3,082 | ||||||||
| Stock-based compensation | 145 | 594 | 739 | ||||||||
| Restructuring and other related costs(1) | (18 | ) | 151 | 133 | |||||||
| Adjusted Gross Profit | $ | 24,647 | $ | 266 | $ | 24,913 | |||||
| Adjusted Gross Margin | 61 | % | 2 | % | 44 | % | |||||
___________________
| (1) | Restructuring and other related costs include severance, restructuring program costs, and other team member costs from workforce reductions and restructuring. For additional details, refer to Note 20 in our condensed consolidated financial statements. |
| Three Months Ended | |||||||||||
| (in thousands, except percentages) | |||||||||||
| Technology | Professional Services | Total | |||||||||
| Revenue | $ | 52,051 | $ | 24,272 | $ | 76,323 | |||||
| Cost of revenue, excluding depreciation and amortization | (17,203 | ) | (21,304 | ) | (38,507 | ) | |||||
| Amortization of intangible assets, cost of revenue | (4,554 | ) | — | (4,554 | ) | ||||||
| Depreciation of property and equipment, cost of revenue | (3,283 | ) | — | (3,283 | ) | ||||||
| Gross profit | 27,011 | 2,968 | 29,979 | ||||||||
| Gross margin | 52 | % | 12 | % | 39 | % | |||||
| Add: | |||||||||||
| Amortization of intangible assets, cost of revenue | 4,554 | — | 4,554 | ||||||||
| Depreciation of property and equipment, cost of revenue | 3,283 | — | 3,283 | ||||||||
| Stock-based compensation | 205 | 991 | 1,196 | ||||||||
| Acquisition-related costs, net(1) | 11 | 24 | 35 | ||||||||
| Restructuring and other related costs(2) | 436 | 650 | 1,086 | ||||||||
| Adjusted Gross Profit | $ | 35,500 | $ | 4,633 | $ | 40,133 | |||||
| Adjusted Gross Margin | 68 | % | 19 | % | 53 | % | |||||
___________________
| (1) | Acquisition-related costs, net include deferred retention expenses attributable to the Upfront, Intraprise, and KPI Ninja acquisitions. For additional details refer to notes 1 and 3 in our condensed consolidated financial statements. |
| (2) | Restructuring and other related costs include severance and other team member costs from workforce reductions and restructuring. For additional details, refer to Note 20 in our condensed consolidated financial statements. |
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP financial measure that we define as net income (loss) adjusted for (i) interest and other expense, net, (ii) income tax provision (benefit), (iii) depreciation and amortization, (iv) stock-based compensation, (v) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities for potential earn-out payments, (vi) restructuring and other related costs, (vii) non-recurring lease-related charges, (viii) gain on sale of business, and (ix) loss on extinguishment of debt, as applicable. We view acquisition-related expenses when applicable, such as transaction costs (including third-party fees associated with due diligence, deferred retention expenses, post-acquisition restructuring costs incurred as part of business combinations) and changes in the fair value of contingent consideration liabilities for potential earnout payments that are directly related to business combinations, as costs that are unpredictable, dependent upon factors outside of our control, and are not necessarily reflective of operational performance during a period. We believe that excluding restructuring and other related costs, impairment of goodwill and intangible assets, non-recurring lease-related charges, loss on extinguishment of debt, and gain on sale of business, as applicable, allows for more meaningful comparisons between operating results from period to period as these are separate from the core activities that arise in the ordinary course of our business and are not part of our ongoing operations. We believe Adjusted EBITDA provides investors with useful information on period-to-period performance as evaluated by management and a comparison with our past financial performance, and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. The following is a reconciliation of our Adjusted EBITDA to net income (loss), the most directly comparable financial measure calculated in accordance with GAAP, for the three months ended
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (in thousands) | |||||||
| Net income (loss) | $ | 40,496 | $ | (22,229 | ) | ||
| Add: | |||||||
| Interest and other expense, net | 540 | 4,679 | |||||
| Income tax provision (benefit) | (393 | ) | 41 | ||||
| Depreciation and amortization | 9,728 | 12,614 | |||||
| Stock-based compensation | 4,077 | 7,039 | |||||
| Acquisition-related costs, net(1) | 1,372 | (1,816 | ) | ||||
| Restructuring and other related costs(2) | 1,354 | 4,772 | |||||
| Non-recurring lease-related charges(3) | — | 6,900 | |||||
| Gain on sale of business(4) | (65,889 | ) | — | ||||
| Loss on extinguishment of debt(5) | 9,494 | — | |||||
| Adjusted EBITDA | $ | 779 | $ | 12,000 | |||
__________________
| (1) | Acquisition-related costs, net include third-party fees associated with due diligence, deferred retention expenses, post-acquisition restructuring costs incurred as part of business combinations, and changes in fair value of contingent consideration liabilities for potential earn-out payments. During the three months ended |
| (2) | Restructuring and other related costs include severance, restructuring and retention program costs, and other team member costs from our restructuring plans, which included workforce reductions, as well as legal and advisory fees related to Project Nexus that are non-recurring and outside the ordinary course of our business. For additional details, refer to Notes 1 and 20 in our condensed consolidated financial statements. |
| (3) | Non-recurring lease-related charges include the lease-related impairment charges related to our corporate office space designated for subleasing. For additional details, refer to Note 10 in our condensed consolidated financial statements. |
| (4) | The gain on sale of business was related to the Vitalware Transaction that closed on |
| (5) | On |
Adjusted Cost of Revenue
Adjusted Cost of Revenue is a non-GAAP financial measure that we define as cost of revenue adjusted for (i) depreciation and amortization, (ii) stock-based compensation, (iii) acquisition-related costs, net, and (iv) restructuring and other related costs, as applicable. We view these adjustments to allow for more meaningful comparisons between operating results from period-to-period as these are separate from the core activities that arise in the ordinary course of our business. Adjusted Cost of Revenue is also computable by subtracting Adjusted Gross Profit from revenue. We believe Adjusted Cost of Revenue provides investors with useful information on period-to-period performance as evaluated by management and a comparison with our past financial performance, and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. The following is a reconciliation of Adjusted Cost of Revenue to our cost of revenue, the most directly comparable financial measure calculated in accordance with GAAP, for the three months ended
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (in thousands) | |||||||
| Cost of revenue, excluding depreciation and amortization | $ | 32,242 | $ | 38,507 | |||
| Add: | |||||||
| Amortization of intangible assets, cost of revenue | 3,614 | 4,554 | |||||
| Depreciation of property and equipment, cost of revenue | 3,082 | 3,283 | |||||
| Cost of revenue | 38,938 | 46,344 | |||||
| Less: | |||||||
| Amortization of intangible assets, cost of revenue | (3,614 | ) | (4,554 | ) | |||
| Depreciation of property and equipment, cost of revenue | (3,082 | ) | (3,283 | ) | |||
| Stock-based compensation | (739 | ) | (1,196 | ) | |||
| Acquisition-related costs, net(1) | — | (35 | ) | ||||
| Restructuring and other related costs(2) | (133 | ) | (1,086 | ) | |||
| Adjusted Cost of Revenue | $ | 31,370 | $ | 36,190 | |||
__________________
| (1) | Acquisition-related costs, net include deferred retention expenses incurred as part of business combinations. |
| (2) | Restructuring and other related costs include severance, restructuring and retention program costs, and other team member costs from our restructuring plans, which included workforce reductions, as well as legal and advisory fees related to Project Nexus that are non-recurring and outside the ordinary course of our business. For additional details, refer to Note 20 in our condensed consolidated financial statements. |
Adjusted Operating Expenses
Adjusted Operating Expenses is a non-GAAP financial measure that we define as total operating expenses adjusted for (i) depreciation and amortization, (ii) stock-based compensation, (iii) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities for potential earn-out payments, (iv) goodwill impairment, (v) restructuring and other related costs, and (vi) non-recurring lease related charges, as applicable. We view these adjustments to allow for more meaningful comparisons between operating results from period-to-period as these are separate from the core activities that arise in the ordinary course of our business. We believe Adjusted Operating Expenses provides investors with useful information on period-to-period performance as evaluated by management and a comparison with our past financial performance, and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. The following is a reconciliation of Adjusted Operating Expenses to our total operating expenses, the most directly comparable financial measure calculated in accordance with GAAP, as well as a calculation of total operating expenses and Adjusted Operating Expenses as a percentage of total revenue, for the three months ended
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (in thousands) | |||||||
| Total operating expenses | $ | 39,793 | $ | 55,325 | |||
| Less: | |||||||
| Depreciation and amortization | (9,728 | ) | (12,614 | ) | |||
| Stock-based compensation | (3,338 | ) | (5,843 | ) | |||
| Acquisition-related costs, net(1) | (1,372 | ) | 1,851 | ||||
| Restructuring and other related costs(2) | (1,221 | ) | (3,686 | ) | |||
| Non-recurring lease-related charges(3) | — | (6,900 | ) | ||||
| Adjusted Operating Expenses | $ | 24,134 | $ | 28,133 | |||
| Total operating expenses as a % of revenue | 71 | % | 73 | % | |||
| Adjusted Operating Expenses as a % of revenue | 43 | % | 37 | % | |||
__________________
| (1) | Acquisition-related costs, net include third-party fees associated with due diligence, deferred retention expenses, post-acquisition restructuring costs incurred as part of business combinations, and changes in fair value of contingent consideration liabilities for potential earn-out payments. During the three months ended |
| (2) | Restructuring and other related costs include severance, restructuring and retention program costs, and other team member costs from our restructuring plans, which included workforce reductions, as well as legal and advisory fees related to Project Nexus that are non-recurring and outside the ordinary course of our business. For additional details, refer to Notes 1 and 20 in our condensed consolidated financial statements. |
| (3) | Non-recurring lease-related charges include the lease-related impairment charges related to our corporate office space designated for subleasing. For additional details, refer to Note 10 in our condensed consolidated financial statements. |
Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share
Adjusted Net Income (Loss) is a non-GAAP financial measure that we define as net income (loss) adjusted for (i) stock-based compensation, (ii) amortization of acquired intangibles, (iii) restructuring and other related costs, (iv) acquisition-related costs, net, including the change in fair value of contingent consideration liabilities, (v) goodwill impairment, (vi) non-cash interest expense related to debt facilities, (vii) non-recurring lease-related charges, (viii) gain on sale of business, and (ix) loss on extinguishment of debt, as applicable. We believe Adjusted Net Income (Loss) provides investors with useful information on period-to-period performance as evaluated by management and comparison with our past financial performance and is useful in evaluating our operating performance compared to that of other companies in our industry, as this metric generally eliminates the effects of certain items that may vary from company to company for reasons unrelated to overall operating performance. The following is a reconciliation of Adjusted Net Income (Loss) to our net income (loss), the most directly comparable financial measure calculated in accordance with GAAP, for the three months ended
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Numerator: | (in thousands, except share and per share amounts) | ||||||
| Net income (loss) | $ | 40,496 | $ | (22,229 | ) | ||
| Add: | |||||||
| Stock-based compensation | 4,077 | 7,039 | |||||
| Amortization of acquired intangibles | 6,373 | 8,823 | |||||
| Restructuring and other related costs(1) | 1,354 | 4,772 | |||||
| Acquisition-related costs, net(2) | 1,372 | (1,816 | ) | ||||
| Non-cash interest expense related to debt facilities | 174 | 817 | |||||
| Non-recurring lease-related charges(3) | — | 6,900 | |||||
| Gain on sale of business(4) | (65,889 | ) | — | ||||
| Loss on extinguishment of debt(5) | 9,494 | — | |||||
| Adjusted Net Income (Loss) | $ | (2,549 | ) | $ | 4,306 | ||
| Denominator: | |||||||
| Weighted-average shares outstanding used in calculating net income (loss) per share, basic and Adjusted Net Income (Loss) per share, basic | 75,386,281 | 70,376,760 | |||||
| Weighted-average shares outstanding used in calculating net income (loss) per share, diluted | 75,932,217 | 70,376,760 | |||||
| Non-GAAP weighted-average shares outstanding used in calculating Adjusted Net Income (Loss) per share, diluted | 75,386,281 | 71,094,489 | |||||
| Net income (loss) per share, basic | $ | 0.54 | $ | (0.32 | ) | ||
| Net income (loss) per share, diluted | $ | 0.53 | $ | (0.32 | ) | ||
| Adjusted Net Income (Loss) per share, basic and diluted | $ | (0.03 | ) | $ | 0.06 | ||
______________
| (1) | Restructuring and other related costs include severance, restructuring program costs, and other team member costs from workforce reductions and restructuring, as well as advisory fees related to Project Nexus that are non-recurring and outside the ordinary course of our business. For additional details, refer to Notes 1 and 20 in our condensed consolidated financial statements. |
| (2) | Acquisition-related costs, net include third-party fees associated with due diligence, deferred retention expenses, post-acquisition restructuring costs incurred as part of business combinations, and changes in fair value of contingent consideration liabilities for potential earn-out payments. During the three months ended |
| (3) | Non-recurring lease-related charges include the lease-related impairment charges related to our corporate office space designated for subleasing. For additional details, refer to Note 10 in our condensed consolidated financial statements. |
| (4) | The gain on sale of business was related to the Vitalware Transaction that closed on |
| (5) | On |
Health Catalyst Investor Relations Contact:
Finance and Investor Relations, SVP
+1 (855)-309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact:
Director,
media@healthcatalyst.com
Source: